These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 18371936

  • 1. Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.
    Damaraju D, Damaraju VL, Brun M, Mowles D, Kuzma M, Berendt RC, Sawyer MB, Cass CE.
    Biochem Pharmacol; 2008 May 15; 75(10):1901-11. PubMed ID: 18371936
    [Abstract] [Full Text] [Related]

  • 2. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ, Unadkat JD.
    Biochem Pharmacol; 2004 Feb 01; 67(3):453-8. PubMed ID: 15037197
    [Abstract] [Full Text] [Related]

  • 3. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
    Clarke ML, Damaraju VL, Zhang J, Mowles D, Tackaberry T, Lang T, Smith KM, Young JD, Tomkinson B, Cass CE.
    Mol Pharmacol; 2006 Jul 01; 70(1):303-10. PubMed ID: 16617163
    [Abstract] [Full Text] [Related]

  • 4. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
    Paproski RJ, Visser F, Zhang J, Tackaberry T, Damaraju V, Baldwin SA, Young JD, Cass CE.
    Biochem J; 2008 Sep 01; 414(2):291-300. PubMed ID: 18462193
    [Abstract] [Full Text] [Related]

  • 5. COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines.
    O'Kane SL, Eagle GL, Greenman J, Lind MJ, Cawkwell L.
    Lung Cancer; 2010 Feb 01; 67(2):160-5. PubMed ID: 19450893
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
    King KM, Damaraju VL, Vickers MF, Yao SY, Lang T, Tackaberry TE, Mowles DA, Ng AM, Young JD, Cass CE.
    Mol Pharmacol; 2006 Jan 01; 69(1):346-53. PubMed ID: 16234483
    [Abstract] [Full Text] [Related]

  • 7. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
    Bone DB, Hammond JR.
    Am J Physiol Heart Circ Physiol; 2007 Dec 01; 293(6):H3325-32. PubMed ID: 17921321
    [Abstract] [Full Text] [Related]

  • 8. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
    Cole PD, Smith AK, Kamen BA.
    Cancer Chemother Pharmacol; 2002 Aug 01; 50(2):111-6. PubMed ID: 12172974
    [Abstract] [Full Text] [Related]

  • 9. Studies of nucleoside transporters using novel autofluorescent nucleoside probes.
    Zhang J, Sun X, Smith KM, Visser F, Carpenter P, Barron G, Peng Y, Robins MJ, Baldwin SA, Young JD, Cass CE.
    Biochemistry; 2006 Jan 31; 45(4):1087-98. PubMed ID: 16430205
    [Abstract] [Full Text] [Related]

  • 10. Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
    Fernández Calotti P, Galmarini CM, Cañones C, Gamberale R, Saénz D, Avalos JS, Chianelli M, Rosenstein R, Giordano M.
    Biochem Pharmacol; 2008 Feb 15; 75(4):857-65. PubMed ID: 18078872
    [Abstract] [Full Text] [Related]

  • 11. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
    Aguayo C, Casado J, González M, Pearson JD, Martín RS, Casanello P, Pastor-Anglada M, Sobrevia L.
    Placenta; 2005 Feb 15; 26(8-9):641-53. PubMed ID: 16085043
    [Abstract] [Full Text] [Related]

  • 12. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
    Sobrero AF, Moir RD, Bertino JR, Handschumacher RE.
    Cancer Res; 1985 Jul 15; 45(7):3155-60. PubMed ID: 3159474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A purine-selective nucleobase/nucleoside transporter in PK15NTD cells.
    Hoque KM, Chen L, Leung GP, Tse CM.
    Am J Physiol Regul Integr Comp Physiol; 2008 Jun 15; 294(6):R1988-95. PubMed ID: 18417653
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole.
    Endres CJ, Unadkat JD.
    Mol Pharmacol; 2005 Mar 15; 67(3):837-44. PubMed ID: 15557207
    [Abstract] [Full Text] [Related]

  • 19. Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).
    Yao SY, Ng AM, Cass CE, Baldwin SA, Young JD.
    J Biol Chem; 2011 Sep 16; 286(37):32552-62. PubMed ID: 21795683
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.